2Yu Q,Geng Y,Sicinski P. Specific protection against breast cancers by cyclin D1 ablation[J].Nature,2001,(6841):1017.
3Paola C,Anna P,Marina R. CyclinD1 expression in node positive (N+)and node-negative (N-) infiltrating human mamarycarcinomas[J].Int J Cancer(Pred Onco1),1999.139.
4Bilalovic N,Vranic S,Basic H,et a l. Immunohistochemical evaluation of Cyclin D1 in breast cancer[J].Croat Me d J,2005,(03):382.
5Gasparini G,Barbaesschi M,Doglioni C. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable nodepositive breast cancer[J].Clinical Cancer Research,1995,(02):189.
6Michalides R,Tiemessen M,Verschoor T. Overexpression of cyclin D1 enhances taxol induced mitotic death.in MCF7 cells[J].Breast Cancer Research and Treatment,2002,(01):55.
